It was good to see the insurance reimbursements kick in so fast. Even without formal coverage, the insurance companies seem to recognize the usefulness of this treatment. Maybe we'll see more doctors who are willing to treat patients with insurance instead of out of pocket?
Best of luck to you, too, KC. I sold all of my shares on approval, but may buy back in over the next few weeks. Breaburn should buy us out at some point - given their current ownership, but that is never a good reason to invest... I see Probuphine doing well enough to increase the share price on its own.